Financials

  • Market Capitalization 444.87 M
  • Employee 71
  • Founded 2010
  • CEO N/A
  • Website www.rezolutebio.com
  • Headquarter Nevada, United States
  • FIGI BBG001XWWHL4
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.55
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2983
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
6.98 USD-3.99%-4.12%-10.40%-21.40%449.10 M USD
2984
OCGN
Ocugen, Inc. - Common Stock
1.32 USD-3.65%-6.38%+8.20%+30.69%447.63 M USD
3011
PRLD
Prelude Therapeutics Incorporated - Common Stock
5.47 USD-13.72%-17.50%+16.14%+355.83%436.53 M USD
3020
CMPX
Compass Therapeutics, Inc. - Common Stock
2.40 USD-4.76%-0.41%+24.35%-30.43%432.21 M USD

新闻